HPRT mutations are relatively rare but can serve as biomarkers for certain types of cancer. For instance, mutations in the HPRT gene have been associated with specific leukemias and lymphomas. Screening for HPRT mutations could help in the early diagnosis and monitoring of these cancers, and inform treatment decisions.
